Navigation Links
Targeting tumor behavior may lead to new liver cancer drugs
Date:6/18/2009

COLUMBUS, Ohio Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.

The researchers wanted to find agents that might reverse the gene changes associated with invasive liver cancer and perhaps stop liver tumors from spreading in the body. Such therapy could greatly improve patient survival, the researchers say.

The findings are published online in the journal Cancer.

"This is an exciting new way to find potentially useful anti-cancer agents," says principal investigator Dr. Tushar Patel, director of hepatology and a researcher with Ohio State's Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.

"For nearly two decades, cancer drug discovery has sought agents that block a single molecular target or pathway," he says. "Our approach identifies agents that could potentially block tumor progression by striking multiple genes that are associated with a particular cancer-related behavior."

New drugs for liver cancer are needed because the disease is widespread worldwide. The most common type of liver cancer, hepatocellular carcinoma, causes 630,000 deaths every year worldwide, and the incidence is rising in many countries, including the United States.

Only one drug is presently approved for treating advanced liver cancer, Patel says. He notes that several new agents are in development for the disease, but each affects just one or another of the many processes that are altered in liver cancer cells.

"We believe that targeting a certain type of tumor behavior might be helpful for liver cancer because many different biochemical pathways in tumor cells can be involved. Most targeted agents affect only one pathway, so a combination of drugs may be needed. Alternatively, new agents that hit multiple targets simultaneously could be used," he says.

Patel and his colleagues began their study by identifying the gene changes present in liver cancers that had invaded neighboring blood vessels.

The researchers then looked for agents that could reverse these changes as a group. They did this using a database called the connectivity map, a collection of data sets that offers a way to compare gene changes caused by a disease with gene changes caused by different chemicals or drugs.

"We queried the gene changes present in invasive liver cancer cells against the connectivity map and looked for compounds that had an opposite effect on these changes," Patel says. "If genes 'A, B and C' were increased in our tumor cells, we wanted to find an agent that decreased genes 'A, B and C'," he says.

Their search identified two compounds: Resveratol, a component of red wine that recently and coincidentally was shown by others to inhibit the ability of liver cancer cells to invade tissues and metastasize, and 17-allylamino-geldanamycin (17-AAG), which has shown anticancer activity in some solid tumors but has not been tested in liver cancer.

Last, the researchers used laboratory tests to verify that the two compounds actually did alter the invasive ability of liver cancer cells.

"This approach is exciting because it can be applied to any well-defined disease behavior," Patel says. "It might also improve the approach to drug discovery and design if some agents were modified to select for a particular genomic profile rather than a single chemical target.

"Overall," he says, "this could be a more relevant way of looking at cancer because we want to block certain disease changes and specific effects such as invasion, metastasis or chemotherapy resistance."


'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
2. Targeting the more lethal form of the cancer rhabdomyosarcoma
3. Edifecs(TM) and Axway Announce a Partnership Targeting Innovative HIPAA 5010 Migration Solutions.
4. Stem Cell Study Offers Hope for Targeting Tumors
5. Migraine prevention by targeting glutamate receptors?
6. Targeting oxidized cysteine through diet could reduce inflammation and lower disease risk
7. Deadly in Pink: New Report Warns Big Tobacco Has Stepped Up Targeting of Women and Girls
8. Targeting the protein AEG1 impairs human liver cancer growth in mice
9. Tobacco Companies Targeting Teens, Study Says
10. APIC 2009 Targeting Zero Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
11. Targeting Cancers Own Stem Cells to Fight Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... This Saturday, January 28, the BCFA ... very special performance by Alabama Symphony Orchestra musicians Yifan Zhou, Mara McClain & Sarah ... dim sum, and exhibitors offer a look at Chinese games, crafts & more. Festivities ...
(Date:1/24/2017)... ... 24, 2017 , ... The results from the American Cancer Society’s ... for prostate cancer patients: incidents of cancer is down as is the likelihood of ... death rate has dropped from its peak of 215.1 in 1991 to 161.2 in ...
(Date:1/24/2017)... ... January 24, 2017 , ... Today, Taza Agua, ... award-winning bottles, designed specifically to optimize the drinking experience for K-Cup coffee, tea ... for introducing the world’s first untouched bottled water purposed exclusively for creating a ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Choosing Wisdom-Solomon’s Proverbs Reclaimed”: ... leadership, gossip, prostitution, adultery, anger, and common sense. , “Choosing Wisdom-Solomon’s Proverbs ... Dr. David Coats. In September of 1983, they flew to Haiti to focus ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 2017 Results show Gamma Knife spares normal ... radiotherapy platforms Elekta (EKTA-B.ST) today announced new ... and delivers a higher radiation dose compared to linear accelerator ... large or complex brain tumors, were published in the ... ...
(Date:1/24/2017)... 24, 2017 www.Financialbuzz.com - ... in the United States as eight ... In addition, Proposition 64, the California Cannabis Legalization Initiative, was ... on November 8, 2016. This outcome means that individuals in ... to grow a certain amount of cannabis for personal use. ...
(Date:1/24/2017)... The global  mammography market  is ... by 2025, according to a new report by Grand ... to the rising initiatives by various governments and NGOs ... in breast tissue. Some significant organizations such as the ... are promoting the early diagnosis of mammary gland calcification, ...
Breaking Medicine Technology: